Key facts
- This page summarizes Kenneth Fletcher Olson's Form 4 filing for HARVARD BIOSCIENCE INC (HBIO).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 30 Dec 2021, 15:19.
Kenneth Fletcher Olson - 29 Dec 2021 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- HBIO
- Reported as of
- 29 Dec 2021
- Net transaction value
- -$44,776
- SEC form
- 4
- Accepted by SEC
- 30 Dec 2021, 15:19:25 UTC
- Prior SEC filing
- 03 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Sirois, by power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kenneth Fletcher Olson filed Form 4 for HARVARD BIOSCIENCE INC (HBIO) on 30 Dec 2021.
Change
- Previous filing in this sequence was filed on 03 Nov 2021.
- Current net transaction value: -$44,776.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HBIO
transaction
Common Stock
Tax liability
- Transaction value
- $20,443
- Shares
- -2,812
- Change %
- -1.7%
- Price
- $7.27
- Shares after
- 158,942
- Date
- 29 Dec 2021
- Ownership
- Direct
- Footnotes
- F1, F2
HBIO
transaction
Common Stock
Tax liability
- Transaction value
- $24,333
- Shares
- -3,347
- Change %
- -2.1%
- Price
- $7.27
- Shares after
- 155,595
- Date
- 29 Dec 2021
- Ownership
- Direct
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with the performance restricted stock unit award previously granted to the Reporting Person that vested in part on December 29, 2021.
Footnote F2
Includes (a) 36,756 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 21,870 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (c) 31,453 restricted stock units with performance based vesting conditions, (d) 18,378 remaining restricted stock units that will vest on December 29, 2022 and 2023, (e) 5,029 remaining restricted stock units that will vest on November 1, 2022, and (f) 45,456 shares of common stock beneficially owned by the Reporting Person (which includes 3,644 shares acquired under the Issuer's Employee Stock Purchase Plan).
Footnote F3
The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with the performance restricted stock unit award previously granted to the Reporting Person that vested in part on December 29, 2021.
Footnote F4
Includes (a) the shares and awards described in footnote (2) above, less (b) the disposition of shares reported in footnote (3) above.